Gainers
- Phunware, Inc. PHUN shares jumped 471.2% to close at $8.74 on Friday. Phunware shares jumped over 45% on Thursday, possibly in sympathy with Digital World Acquisition as traders circulated an article from May 2020 highlight a partnership between Phunware and the former Trump campaign.
- Digital World Acquisition Corp. DWAC gained 107% to settle at $94.20. Digital World Acquisition surged around 357% on Thursday following an announcement the company will merge with Trump Media & Technology Group.
- SG Blocks, Inc. SGBX jumped 42.4% to close at $4.80 as traders circulated a report indicating Donald Trump Jr. in 2012 entered a two-year consulting agreement with the company. Trump-related stocks have surged today in sympathy with Digital World Acquisition.
- Creatd, Inc. CRTD shares rose 41.4% to close at $4.13. WHE Agency parent company Creatd signed creator Alexis LaRue. The financial terms of the contract remain undisclosed.
- Portillo's Inc. PTLO climbed 28.6% to close at $37.43. Portillo's rose 45% on Thursday after the company priced its IPO at $20 per share.
- Grom Social Enterprises, Inc. GROM gained 28.5% to close at $4.56. Grom Social Enterprises amended private placement to increase total raise to up to $10.4 million.
- Yunhong CTI Ltd. CTIB climbed 27.6% to settle at $2.66.
- Aurinia Pharmaceuticals Inc. AUPH gained 26.8% to close at $28.00. Bristol-Myers is said to make a takeover approach to Aurinia, Bloomberg reported.
- Salem Media Group, Inc. SALM shares jumped 26.7% to close at $4.70. Salem Media shares being traded as another sympathy play with momentum in Digital World Acquisition shares.
- Biotricity, Inc. BTCY surged 22% to settle at $4.24 on above-average volume.
- Babylon Holdings Ltd. BBLN gained 18.5% to close at $10.90.
- Progenity, Inc. PROG surged 18.4% to close at $2.96 on abnormally-high volume.
- Benessere Capital Acquisition Corp. BENE gained 15.7% to close at $11.69. CEO Patrick Orlando is Chairman and COE of Digital World Acquisition Corp.
- GasLog Partners LP GLOP rose 14.3% to close at $5.19 after Jefferies upgraded the stock from Hold to Buy and raised its price target from $5 to $6.5.
- Bakkt Holdings, Inc. BKKT gained 14% to settle at $9.15.
- Dutch Bros Inc. BROS surged 13.7% to close at $68.86 amid post-IPO volatility.
- Context Therapeutics Inc. CNTX climbed 13.3% to close at $6.99 amid post-IPO volatility.
- Cleveland-Cliffs Inc. CLF rose 12.7% to close at $23.85 after the company reported better-than-expected Q3 EPS and sales results.
- Foresight Autonomous Holdings Ltd. FRSX gained 12.3% to close at $3.28.
- Athira Pharma, Inc. ATHA gained 11.2% to settle at $10.71. Athira Pharma reported completion of enrollment in Phase 2 ACT-AD trial evaluating ATH-1017 for mild-to-moderate Alzheimer's disease. The company announced the appointment of Mark Litton, who was serving as the company's chief operating officer, as its chief executive officer.
- WeWork WE gained 10.5% to close at $13.02 after gaining over 13% on Thursday.
- Treace Medical Concepts, Inc. TMCI jumped 10.2% to close at $21.98. Treace announced grant of additional U.S. patent on instrumented bunion correction.
- Olin Corporation OLN gained 9.4% to settle at $56.40 after the company reported better-than-expected Q3 EPS results.
- T2 Biosystems, Inc. TTOO rose 6.3% to close at $0.8784 after the company announced distribution agreements in key Asia-Pacific markets.
Check out these big penny stock gainers and losers
Losers
- Metacrine, Inc. MTCR shares fell 57.4% to close at $1.63 on Friday after the company reported interim results for the MET642 Phase 2a trial in patients with NASH and announced a strategic reprioritization of its clinical development programs.
- Xiaobai Maimai Inc. HX shares fell 38.5% to close at $5.62 after dropping over 50% on Thursday.
- Ocular Therapeutix, Inc. OCUL dropped 36.2% to settle at $6.91 after the company announced topline results for its Phase 2 clinical trial of OTX-CSI for the treatment of dry eye disease did not meet the primary endpoint.
- Snap Inc. SNAP shares dipped 26.6% to close at $55.14. Snap reported upbeat earnings for its third quarter, while sales missed expectations. The company also issued Q4 sales guidance below estimates.
- Cambium Networks Corporation CMBM fell 26.4% to close at $27.40 after the company cut its Q3 2021 revenue guidance, noting 'greater than anticipated global supply constraints.'
- Minerva Surgical, Inc. UTRS dropped 25% to settle at $9.00 after pricing its IPO at $12 per share.
- Seaport Global Acquisition Corp SGAM fell 24.8% to close at $9.62 after surging 33% on Thursday.
- Socket Mobile, Inc. SCKT shares dipped 24.6% to close at $6.77 after the company announced Q3 earnings results.
- Eargo, Inc. EAR fell 23.8% to close at $7.78.
- Cambium Networks Corporation CMBM dropped 23.4% to settle at $27.40 after the company cut its Q3 2021 revenue guidance, noting 'greater than anticipated global supply constraints.'
- Agenus Inc. AGEN declined 21.8% to close at $4.01 after the company provided an update on balstilimab development.
- Altus Midstream Company ALTM fell 19.9% to close at $68.01 after the company, and EagleClaw, announced an all-stock business combination.
- Big Cypress Acquisition Corp. BCYP dropped 19.2% to settle at $8.44. Big Cypress Acquisition stockholders recently approved business combination with SAB Biotherapeutics.
- China Finance Online Co. Limited JRJC declined 17.6% to close at $7.52 after jumping more than 20% on Thursday.
- X Financial XYF dropped 17.2% to close at $5.05.
- Nutriband Inc. NTRB declined 15.8% to close at $4.90. Nutriband received additional $2,062,500 from exercise of warrants.
- ClearOne, Inc. CLRO fell 15.8% to settle at $1.76.
- InMed Pharmaceuticals Inc. INM shares fell 15.2% to settle at $1.62. InMed Pharmaceuticals recently announced completion of BayMedica acquisition.
- Sio Gene Therapies Inc. SIOX fell 14.4% to close at $2.02. Sio Gene Therapies recently announced it was granted FDA Fast Track Designation for its investigational AXO-AAV-GM1 gene therapy.
- Mesabi Trust MSB fell 14.3% to settle at $30.80. Mesabi Trust recently declares a $1.42/unit dividend.
- Shapeways Holdings, Inc. SHPW dropped 14.1% to close at $8.23. Shapeways Holdings S-1 recently showed registration for 35.5 million share and 4 million warrants to buy shares shelf offering.
- U.S. Xpress Enterprises, Inc. USX fell 13.8% to close at $8.01 after the company reported worse-than-expected Q3 EPS results. Following earnings, B of A Securities downgraded the stock from Neutral to Underperform.
- ION Geophysical Corporation IO dipped 13.7% to close at $1.95. ION Geophysical recently issued Q3 sales guidance above estimates.
- Vinco Ventures, Inc. BBIG fell 13.4% to close at $5.19. The company recently reported the CEO and CFO resigned and transitioned into other roles within the company at Vinco Venture's parent company ZASH Global Media and a Vinco Ventures subsidiary, Cryptyde.
- JX Luxventure Limited LLL dropped 11.1% to close at $2.96.
- Intel Corporation INTC shares declined 11.7% to close at $49.46. Intel reported upbeat earnings for the third quarter, while sales missed estimates.
- Ventyx Biosciences, Inc. VTYX fell 11.3% to close at $18.65. Ventyx Biosciences gained 31% on Thursday after pricing its IPO at $16 per share.
- Camber Energy, Inc. CEI shares fell 11.1% to close at $1.44 after declining over 10% on Thursday.
- Kaival Brands Innovations Group, Inc. KAVL fell 10.9% to close at $1.56 after dipping over 10% on Thursday.
- PubMatic, Inc. PUBM fell 10.2% to close at $26.51.
- Sesen Bio, Inc. SESN fell 8% to close at $1.15. The FDA recently granted Sesen Bio’s request for a Type A meeting to discuss issued raised in the FDA's Complete Response Letter related to vicineum.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Posted In: NewsPenny StocksSmall CapPre-Market OutlookMarketsMoversTrading IdeasAerospace & DefenseIndustrialsInformation TechnologyIT Consulting & Other ServicesMovers From Yesterday
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in